Zinc finger protein 662 (ZNF662) is a member of the zinc finger protein superfamily, which is one of the largest families of transcription factors in eukaryotic organisms. The defining feature of zinc finger proteins is their zinc finger domains, which are small, functional, independently folded units that stabilize protein structure through coordination with a zinc ion. These domains enable the protein to interact with other molecules, such as DNA, RNA, or proteins, in a sequence-specific manner.
ZNF662, like many zinc finger proteins, likely functions as a transcriptional regulator, binding to specific DNA sequences to control the expression of certain genes. The C2H2-type zinc fingers in ZNF662, which are the most common type of zinc fingers in transcription factors, consist of a short beta-sheet and an alpha-helix, with the zinc ion held in place by conserved cysteines and histidines. The alpha-helix typically contacts the major groove of the DNA, allowing for the recognition and binding of particular genetic elements.While much of ZNF662's specific biological roles and target genes remain to be fully characterized, its structural motifs suggest a role in gene regulation, potentially impacting processes like cell differentiation, growth, and response to stress. The precise DNA-binding specificity of ZNF662 is determined by the amino acid sequence within its zinc finger domains, and variations in these sequences can lead to differential gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $127.00 | 10 | |
Zinc chelators like TPEN might indirectly affect ZNF662 by altering zinc availability, crucial for the function of zinc finger proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitors such as Trichostatin A could indirectly influence ZNF662 by modifying chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may affect ZNF662 indirectly by altering gene expression patterns through DNA methylation changes. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
JAK/STAT inhibitors like Ruxolitinib could indirectly impact ZNF662 by modulating pathways involved in gene expression and cell signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, a PI3K/Akt/mTOR inhibitor, might affect ZNF662 indirectly by altering signaling pathways that intersect with DNA binding and gene regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Bromodomain inhibitors like JQ1 may influence ZNF662 indirectly by affecting transcription regulation and chromatin remodeling. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
HSP90 inhibitors like 17-AAG could indirectly influence ZNF662 by affecting protein stability and function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Splicing inhibitors such as Pladienolide B may indirectly impact ZNF662 by altering RNA splicing processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin, an RNA polymerase inhibitor, could indirectly affect ZNF662 by impacting RNA synthesis and processing. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitors like Bortezomib may influence ZNF662 indirectly by modulating protein degradation pathways. |